Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genpathway was a systems biology company specializing in genome-wide epigenetic studies and chromatin immunoprecipitation (ChIP) services. Based in San Diego, the company provided proprietary technologies such as FactorPath and TranscriptionPath to identify transcription factor binding sites and analyze gene regulation. Their services supported pharmaceutical and biotechnology companies in drug discovery, biomarker identification, and mechanism of action studies. The company's platform enabled the identification of direct target genes for transcription factors and coactivators, accelerating the characterization of regulatory pathways. In 2010, Genpathway was acquired by Active Motif to expand its epigenetics product and service portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GENpathway.